Midday analysis of limit-up and limit-down stocks: 52 stocks hit the limit-up, 8 stocks hit the limit-down. Innovative medicine concept is active, Wanbangde hits the limit-up 5 times in 7 days.

Ask AI: Is the active state of innovative drug concepts related to favorable industry policy news?

On the afternoon of April 1, during the first half of the trading day, A-shares had 52 stocks hitting the daily limit up and 8 stocks hitting the limit down. The innovative drug concept remained active: Wanbangde saw 5 of 7 days hitting the limit up, Lianhuan Pharmaceutical 3 of 4 days hitting the limit up, and Wan Ze Shares, Guangshengtang, and others also hit limit up; the chemical pharmaceutical sector strengthened, with Tianjin Yaoye achieving four consecutive limit-up days.

For stocks with consecutive limit-up days: Orydd reached 6 limit-ups over 11 days, *ST Jiyou 5 over 6 days, 9an Healthcare 3 over 4 days, Xihua Technology 2 over 4 days, Guosheng Technology and Ningbo Fuda 2 over 3 days, and two-day limit-ups such as Kailaiying and Shengyang Shares. Shipping such as China Merchants Container Lines and Huaqin Technology also hit limit up.

*ST Jinglun saw five consecutive days of limit-down, *ST Wanfang three consecutive days of limit-down, *ST Guohua and *ST Panda two consecutive days of limit-down, and ST Xifa, Jinqi Technology, and others also hit limit down.